News | News By Subject | News by Disease News By Date | Search News

Sepsis News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
French Startup Inotrem Bags $25 Million To Develop Sepsis Drugs     3/14/2014
AstraZeneca PLC (AZN), BTG plc (BGC.L) Scrap Sepsis Drug as Trial Fails     8/9/2012
Agennix AG Halts Phase II/III OASIS Trial in Severe Sepsis     2/2/2012
Eli Lilly and Company (LLY) to Withdraw Xigris From Market Worldwide     10/26/2011
Eisai Company, Ltd. (ESALY.PK)'s Phase III Study for Eritoran Does Not Meet Primary Endpoint     1/25/2011
Eisai Inc. (ESALF.PK) To Delay Application For Sepsis Drug Eritoran     3/26/2010
Cepheid (CPHD) And bioMerieux, Inc. Enter Into Strategic Agreements To Develop And Market Sepsis And MRSA Products     1/17/2007
Protherics PLC And AstraZeneca PLC (AZN) Updates CytoFab(TM) Development Programme; New Trial To Delay Drug     11/3/2006
Dutch Biopharmaceutical Company AM-Pharma Holding BV Announces Positive Results In Its Double-Blind, Placebo Controlled Phase IIa Sepsis Trial With Alkaline Phosphatase     10/20/2006
Eli Lilly and Company's (LLY) Sepsis Drug Fails To Help Patients At Low Risk Of Death     9/29/2005
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Receives FDA Fast Track Designation For TAK-242, Investigational Compound For Severe Sepsis     7/29/2005
Eli Lilly and Company (LLY) Stops Pediatric Trial Of Sepsis Drug     4/29/2005

News from Around the Web
Resiniferatoxin May Increase Sepsis-Related Mortality, Children's National Medical Center Study     4/27/2011
Roundworm Could Provide New Treatment for Sepsis, University of Liverpool Study     3/9/2011
Vitamin C: A Potential Life-saving Treatment for Sepsis, The University of Western Ontario and Lawson Health Research Institute Study     11/18/2010
Sepsis Leaves Long Legacy on Brain and Body, University of Michigan Study     10/27/2010
New Clue to Deadly Sepsis as More Aggressive Care Urged , Ohio State University Medical Center Study     10/5/2010
The Potential To Treat Or Prevent Sepsis And Severe Infection By Blocking The 'Programmed Death 1' Protein, Washington University Study     8/4/2010
Milk Protein Supplement Prevents Sepsis in Preterm Infants, S. Anna Hospital Study     10/7/2009
Potential Drug Targets For Sepsis Discovered by The Scripps Research Institute Researchers     2/29/2008
National Institutes of Health (NIH): Eli Lilly and Company (LLY) Influenced Sepsis Treatment     10/19/2006
New Study Finds Key Role For VEGF In Onset Of Sepsis     5/19/2006
Protein Prevents Detrimental Immune Effects Of Bacterial Sepsis     5/23/2005

Press Releases
Immunexpress Release: SeptiCyte LAB Differentiates Sepsis From Infection-Negative Systemic Inflammation In Critically Ill Children     9/23/2016
Inotrem Successfully Completes Its First Phase I Clinical Trial With Motrem, A TREM-1 Pathway Modulator For The Treatment Of Septic Shock     9/13/2016
Roche (RHHBY) Receives FDA Clearance For Its Procalcitonin (PCT) Assay To Help Clinicians Effectively Assess Sepsis Risk And Manage Sepsis Patients     6/23/2016
Immunexpress Presents Results Indicating The Utility Of SeptiCyte For The Diagnosis Of Sepsis In Critically Ill Children At The 45th Annual Society Of Critical Care Medicine Congress     2/22/2016
T2 Biosystems (TTOO) Announces Leading Hospitals Adopting T2Candida For Sepsis Detection     10/29/2015
Astute Medical Highlights Study Of NephroCheck Test Biomarkers In Patients With Sepsis     10/21/2015
American College of Chest Physicians Release: Study Finds No Increased Risk Of Mortality When Patients With Sepsis Were Stabilized In ED Prior To ICU Admission     10/20/2015
T2 Biosystems (TTOO) Release: New Study For T2Candida Panel Published In Future Microbiology     9/16/2015
Yabao Pharmaceuticals Starts Preclinical Studies On Sepsis Treatment     7/28/2015
TiGenix Completes Treatment In Phase I Sepsis Challenge Trial With Cx611     3/12/2015
Par Pharmaceutical, Inc. Announces First FDA Approval Of Vasostrict™ (Vasopressin Injection, USP)     11/12/2014
SanguiBioTech GmbH: Preclinical Trials Demonstrate: Sangui Hemoglobin Preparation Improves Oxygen Supply Of Vital Organs     11/11/2014
TiGenix Announces The Clinical Development Of Cx611 In Early Rheumatoid Arthritis And Severe Sepsis     6/30/2014
SignaBlok Achieves Key in Vivo Proof of Concept for Treatment of Cancer and Sepsis     9/17/2013
Scienion AG's sciFLEXARRAYER Used for the Production of Anagnostics' Integrated Sepsis Testing Products     12/11/2012

//-->